An experimental blood test may one day detect the return of early stage breast cancer months before it is revealed by CT or MRI scans, researchers report. Tilak Sundaresan, clinical fellow in medicine at Brigham and Women’s Hospital, the Dana-Farber Cancer Institute and Massachusetts General Hospital, who co-authored a commentary published with the report, is quoted.
